Urinary hesitancy: Difference between revisions
(→Causes) |
Kiran Singh (talk | contribs) |
||
(14 intermediate revisions by 3 users not shown) | |||
Line 4: | Line 4: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} hesitancy; delayed urination; difficulty initiating urination | {{SK}} hesitancy; delayed urination; difficulty initiating urination; weak urine stream | ||
==Overview== | ==Overview== | ||
Line 12: | Line 12: | ||
=== Common Causes === | === Common Causes === | ||
*[[Anticholinergics]] | |||
*[[Benign prostatic hyperplasia]] | |||
*[[Prostatic cancer]] | |||
*[[Prostatitis]] | |||
*[[Shy bladder syndrome]] | |||
*[[Tricyclic antidepressants]] | |||
*[[Urinary tract infection]] | |||
*[[Urinary tract obstruction]] | |||
=== Causes by Organ System === | === Causes by Organ System === | ||
Line 29: | Line 38: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Amitriptyline]], [[Amoxapine]], [[Anticholinergics]], [[Hyoscyamine]], [[Nasal decongestants]], [[Norpramin]], [[Orphenadrine]], [[Pamelor]], [[Repaglinide]], [[Sinequan]], [[Surmontil]], [[Tofranil]], [[Tricyclic antidepressants]], [[Vivactil ]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 37: | Line 46: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Diabetes mellitus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 53: | Line 62: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Blood clot in the urethra]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Recovery from general anesthesia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Herpes genitalis]], [[Herpes zoster]], [[Tabes dorsalis]], [[Urinary tract infection]], [[Prostatitis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal / Ortho''' | | '''Musculoskeletal / Ortho''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Secondary tumor deposits in vertebra]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Multiple sclerosis]], [[Pudendal nerve entrapment]], [[Spinal cord lesions]], [[Syringomyelia]], [[Transverse myelitis]], [[Tabes dorsalis]], [[Tumor of the spinal meninges]], [[Tumor of the spinal cord]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 77: | Line 86: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Retroverted pregnancy]], [[Uterine fibroids]], [[Vaginal carcinoma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Secondary tumor deposits in vertebra]], [[Tumor of the spinal meninges]], [[Urethral carcinoma]], [[Vaginal carcinoma ]], [[Prostatic cancer]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 89: | Line 98: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose / Toxicity''' | | '''Overdose / Toxicity''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Amitriptyline]], [[Amoxapine]], [[Anticholinergics]], [[Nasal decongestants]], [[Norpramin]], [[Pamelor]], [[Sinequan]], [[Surmontil]], [[Tofranil]], [[Tricyclic antidepressants]], [[Vivactil ]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Bashful bladder syndrome]], [[Shy bladder syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 105: | Line 114: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheum / Immune / Allergy''' | | '''Rheum / Immune / Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Multiple sclerosis]], [[Transverse myelitis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 117: | Line 126: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Urologic''' | | '''Urologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Bashful bladder syndrome]], [[Benign prostatic hyperplasia]], [[Benign prostatic hypertrophy]], [[Bladder diverticulum]], [[Blood clot in the urethra]], [[Meatal stenosis]], [[Poor bladder contractility]], [[Posterior strictures in males]], [[Primary bladder neck dysfunction]], [[Prostatic cancer]], [[Prostatitis]], [[Shy bladder syndrome]], [[Tight phimosis]], [[Tumor of the spinal cord]], [[Urethral stricture]], [[Urinary tract obstruction]], [[Urinary tract infection]], [[Urethral carcinoma]], [[Reflux nephropathy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 156: | Line 165: | ||
{{ColBreak}} | {{ColBreak}} | ||
*[[Recovery from general anesthesia]] | *[[Recovery from general anesthesia]] | ||
*[[Reflux nephropathy]] | |||
*[[Retroverted pregnancy]] | *[[Retroverted pregnancy]] | ||
*[[Secondary tumor deposits in vertebra]] | *[[Secondary tumor deposits in vertebra]] | ||
Line 164: | Line 174: | ||
*[[Syringomyelia]] | *[[Syringomyelia]] | ||
*[[Tabes dorsalis]] | *[[Tabes dorsalis]] | ||
*[[Tight | *[[Tight phimosis]] | ||
*[[Tofranil]] | *[[Tofranil]] | ||
*[[Transverse myelitis]] | *[[Transverse myelitis]] | ||
Line 178: | Line 188: | ||
*[[Vivactil ]] | *[[Vivactil ]] | ||
{{EndMultiCol}} | {{EndMultiCol}} | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Line 203: | Line 197: | ||
* Catheterization of the bladder to determine residual [http://www.nlm.nih.gov/medlineplus/ency/article/003425.htm urine volume] and to get urine for culture (a [http://www.nlm.nih.gov/medlineplus/ency/article/003752.htm catheterized urine specimen]) | * Catheterization of the bladder to determine residual [http://www.nlm.nih.gov/medlineplus/ency/article/003425.htm urine volume] and to get urine for culture (a [http://www.nlm.nih.gov/medlineplus/ency/article/003752.htm catheterized urine specimen]) | ||
* [[Cystometrography]] | * [[Cystometrography]] | ||
* [[Transrectal ultrasound]] of the [[prostate]] (similar to a [[transvaginal ultrasound]] | * [[Transrectal ultrasound]] of the [[prostate]] (similar to a [[transvaginal ultrasound]]) | ||
* [[Urethral swab]] for culture | * [[Urethral swab]] for culture | ||
* [[Urinalysis]] and culture | * [[Urinalysis]] and culture | ||
Line 214: | Line 208: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Symptoms]] | |||
[[Category:Signs and symptoms]] | [[Category:Signs and symptoms]] | ||
[[Category:Urology]] | [[Category:Urology]] |
Latest revision as of 14:51, 16 June 2015
For patient information click here
WikiDoc Resources for Urinary hesitancy |
Articles |
---|
Most recent articles on Urinary hesitancy Most cited articles on Urinary hesitancy |
Media |
Powerpoint slides on Urinary hesitancy |
Evidence Based Medicine |
Cochrane Collaboration on Urinary hesitancy |
Clinical Trials |
Ongoing Trials on Urinary hesitancy at Clinical Trials.gov Trial results on Urinary hesitancy Clinical Trials on Urinary hesitancy at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Urinary hesitancy NICE Guidance on Urinary hesitancy
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Urinary hesitancy Discussion groups on Urinary hesitancy Patient Handouts on Urinary hesitancy Directions to Hospitals Treating Urinary hesitancy Risk calculators and risk factors for Urinary hesitancy
|
Healthcare Provider Resources |
Causes & Risk Factors for Urinary hesitancy |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: hesitancy; delayed urination; difficulty initiating urination; weak urine stream
Overview
Urinary hesitancy is defined as difficulty in initiating and maintaining a flow of urine.
Causes
Common Causes
- Anticholinergics
- Benign prostatic hyperplasia
- Prostatic cancer
- Prostatitis
- Shy bladder syndrome
- Tricyclic antidepressants
- Urinary tract infection
- Urinary tract obstruction
Causes by Organ System
Causes in Alphabetical Order
Epidemiology and Demographics
Urinary hesitancy is observed in both genders at all ages. It tends to affect elderly males more frequently.
Diagnosis
Laboratory Studies
The following diagnostic studies may be of use:
- Catheterization of the bladder to determine residual urine volume and to get urine for culture (a catheterized urine specimen)
- Cystometrography
- Transrectal ultrasound of the prostate (similar to a transvaginal ultrasound)
- Urethral swab for culture
- Urinalysis and culture
- Voiding cystourethrogram
Treatment
Treatment for urinary hesitancy depends on the cause. Often, medications such as alpha-blockers can relieve the symptoms. If you have a bacterial infection, your health care provider may prescribe antibiotics. You may need surgery to relieve a prostate obstruction (see TURP).